絞り込み

16641

広告

救急医療管理加算に「重症度スコア」記載を要件化へ (日経BP)

厚生労働省の中央社会保険医療協議会(中医協)は2019年12月4日の総会で、救急医療や小児・周産期医療、癌対策、脳卒中、生活習慣病をテーマに、診療報酬上の評価の...

  1. 導入療法で寛解した55歳以上の急性骨髄性...
  2. 疑問氷解:人間に育てられた犬や猫は、動物...
  3. [医学] 手や腕の動作に携わる脳の運動皮...
  4. SRC/ABLチロシンキナーゼ阻害薬ボス...

ニュース一覧

Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling.

著者 Mazzocchi M , Wyatt SL , Mercatelli D , Morari M , Morales-Prieto N , Collins LM , Sullivan AM , O'Keeffe GW
Front Cell Dev Biol.2019 ; 7():191.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (1view , 0users)

Full Text Sources

Miscellaneous

Parkinson's disease is characterized by the intracellular accumulation of α-synuclein which has been linked to early dopaminergic axonal degeneration. Identifying druggable targets that can promote axonal growth in cells overexpressing α-synuclein is important in order to develop strategies for early intervention. Class-IIa histone deacetylases (HDACs) have previously emerged as druggable targets, however, it is not known which specific class-IIa HDACs should be targeted to promote neurite growth in dopaminergic neurons. To provide insight into this, we used gene co-expression analysis to identify which, if any, of the class-IIa HDACs had a positive correlation with markers of dopaminergic neurons in the human substantia nigra. This revealed that two histone deacetylases, and , are co-expressed with and in the human SN. We further found that HDAC5 and HDAC9 are expressed in dopaminergic neurons in the adult mouse substantia nigra. We show that siRNAs targeting or can promote neurite growth in SH-SY5Y cells, and that their pharmacological inhibition, using the drug MC1568, promoted neurite growth in cultured rat dopaminergic neurons. Moreover, MC1568 treatment upregulated the expression of the neurotrophic factor, , and its downstream transcription factor, . In addition, MC1568 or siRNAs targeting or led to an increase in Smad-dependent GFP expression in a reporter assay. Furthermore, MC1568 treatment of cultured rat dopaminergic neurons increased cellular levels of phosphorylated Smad1, which was prevented by the BMP receptor inhibitor, dorsomorphin. Dorsomorphin treatment prevented the neurite growth-promoting effects of siRNAs targeting HDAC5, as did overexpression of dominant-negative Smad4 or of the inhibitory Smad7, demonstrating a functional link to BMP signaling. Supplementation with BMP2 prevented the neurite growth-inhibitory effects of nuclear-restricted HDAC5. Finally, we report that siRNAs targeting or promoted neurite growth in cells overexpressing wild-type or A53T-α-synuclein and that MC1568 protected cultured rat dopaminergic neurons against the neurotoxin, MPP. These findings establish HDAC5 and HDAC9 as novel regulators of BMP-Smad signaling, that additionally may be therapeutic targets worthy of further exploration in iPSC-derived human DA neurons and models of Parkinson's disease.
PMID: 31572723 [PubMed]
印刷用ページを開く Endnote用テキストダウンロード